The Newcastle Scale

Carney, M. W. P.

doi:10.1007/978-3-642-70486-4_19

Cited by 8 publications

(3 citation statements)

References 61 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Depressed clients are more likely to benefit from antidepressant medications if they present with the depressive symptoms of early morning awakenings, decreased interest in life activities, loss of appetite, decreased energy, and feelings of guilt (Nelson, Mazure, Quinlan, & Jatlow, 1984). Additionally, clients with endogenous depression have been found to respond well to electroconvulsive therapy (Carney, 1986;Fowles & Gersh, 1979), and those who have bipolar depression or major depression with psychotic features are best treated pharmacologically.…”

Section: Assess the Need For Psychotropic Medicationsmentioning

confidence: 97%

Cognitive-behavioral treatment of depression, part I: Assessment of depression and suicide risk

Overholser

1995

J Contemp Psychother

View full text Add to dashboard Cite

show abstract

Section: Assess the Need For Psychotropic Medicationsmentioning

confidence: 97%

Cognitive-behavioral treatment of depression, part I: Assessment of depression and suicide risk

Overholser

1995

J Contemp Psychother

View full text Add to dashboard Cite

show abstract

“…Procedure Thirty-nine variables were included in the factor analysis. In addition to the depressive characteristics (symptoms), which were estimated by HDRS with 21 characteristics (Hamilton, 1967), MMPI, BPRS (Overall & Gorham, 1967) and Newcastle scale (Carney, 1986), a certain number of sociodemographic data and life events (broken home, conflict situations) were included. The analysis also included certain characteristics of the course of illness (acute onset, recidivity, etc.)…”

Section: Subjectsmentioning

confidence: 99%

Factor analytic study of depressive disorders

Bíró

Till

1989

J. Clin. Psychol.

View full text Add to dashboard Cite

369In summary, the findings of this investigation support the concurrent validity of many of the MMPI scales for DSM-I11 personality disorders. The failure of some MMPI scales to show adequate convergent validity is probably due to inappropriate criterion measures. Of course, the results of this study are based on a relatively small sample of psychiatric patients and need to be replicated on other populations that have higher representations of outpatients. Also, because patients were referred for psychological testing, they may constitute a sample of more "difficult" or "interesting" patients. This limitation should be kept in mind when conclusions are drawn from these results. In addition, other external criterion measures should be utilized in order to advance the validity of both the MMPI and MCMI personality disorder scales.

show abstract

“…Entry criteria included DSM-III diagnosis of major depression, Hamilton De pression Rating Scale (HAM-D) score of at least 20 points on the 21-item scale [11], and at least 6 points on the Newcastle Scale [12]. After a 1-week placebo washout period, pa tients were randomly assigned to paroxetine or clomipramine.…”

mentioning

confidence: 99%

An Overview of Paroxetine in the Elderly

Dünner

1994

Gerontology

View full text Add to dashboard Cite

Depression in the elderly is an increasingly prevalent problem affecting some 15% of the elderly population and can be difficult to diagnose and treat. Complicating factors include poor compliance, the high frequency of concomitant disease, and the alterations in drug absorption and metabolism with age. This paper reviews controlled studies of the treatment of depression in elderly patients using paroxetine, a selective serotonin reuptake inhibitor. The studies demonstrate that paroxetine has efficacy in these patients which is similar to that of comparative compounds. The side effect profile of paroxetine is favourable, as compared with tricyclics, in terms of cardiovascular effects. The side effects of paroxetine in the elderly are similar to those reported in younger individuals. The improved tolerability profile of paroxetine is particularly welcome for the treatment of the elderly who have an increased sensitivity to adverse effects of drug therapy.

show abstract

The Newcastle Scale

Cited by 8 publications

References 61 publications

Cognitive-behavioral treatment of depression, part I: Assessment of depression and suicide risk

Cognitive-behavioral treatment of depression, part I: Assessment of depression and suicide risk

Factor analytic study of depressive disorders

An Overview of Paroxetine in the Elderly

Contact Info

Product

Resources

About